International Publications Archive - Seite 192 von 223 - IOZK

Immune and clinical outcomes in patients with stage IV melanoma vaccinated with peptide-pulsed dendritic cells derived from CD34+ progenitors and activated with type I interferon

2005-09-01/in International Publications, Malignant Melanoma /von 2005-09-01 / J. Immunother. 2005 Sep-Oct;28(5):505-16

[Vaccine therapy of prostate cancer]

2005-09-01/in International Publications, Prostate Cancer /von 2005-09-01 / Aktuelle Urol 2005 Sep;36(5):407-16

B-cell lymphoma and myeloma protection induced by idiotype vaccination with dendritic cells is mediated entirely by T cells in mice

2005-09-01/in International Publications, Malignant Lymphoma /von 2005-09-01 / J. Immunother. 2005 Sep-Oct;28(5):461-6

Vaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells: a clinical trial

2005-09-01/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2005-09-01 / J. Immunother. 2005 Sep-Oct;28(5):496-504

Immunomodulatory dendritic cells require autologous serum to circumvent nonspecific immunosuppressive activity in vivo

2005-08-23/in Dendritic Cells, International Publications /von 2005-08-23 / Blood 2005 Dec;106(13):4225-33

Antitumor activity of a fusion of esophageal carcinoma cells with dendritic cells derived from cord blood

2005-08-18/in Esophageal Carcinoma, International Publications /von 2005-08-18 / Vaccine 2005 Nov;23(45):5225-30

First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinoma

2005-08-15/in Cervical Cancer, International Publications /von 2005-08-15 / Cancer 2005 Aug;104(4):763-70

Prognostic significance of CD83 positive, mature dendritic cells in the gallbladder carcinoma

2005-08-01/in Gallbladder Cancer, International Publications /von 2005-08-01 / Oncol. Rep. 2005 Aug;14(2):353-6

Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment

2005-08-01/in Dendritic Cells, Glioblastoma, International Publications /von 2005-08-01 / Clin. Cancer Res. 2005 Aug;11(15):5515-25

Tumor-targeted gene transfer in vivo via recombinant Newcastle disease virus modified by a bispecific fusion protein

2005-08-01/in International Publications, Newcastle Disease Virus /von 2005-08-01 / Int. J. Oncol. 2005 Aug;27(2):377-84